Merrimack Pharmaceuticals Selects Patients for Experimental Drug Trial In NSCLC Patients
Lung cancer News, News
Advanced Cell Diagnostics, Inc. (ACD) a company that provides a sensitive and specific RNA hybridization technology, recently announced that Merrimack Pharmaceutical is utilizing their leading technology to choose participants for a ... Read more